Lantern Pharma Inc.
Dallas, United States
Dr. Aditya Kulkarni is a Senior Research Scientist and Program Manager at Lantern Pharma. He is a biopharmaceutical research scientist, manager, and inventor combining over 10 years of research experience with a vision to integrate science and business to direct drugs from bench to bedside. He welcomes challenges, embraces scientific rigor, and co-creates vision and strategy in an effort to move the organizational portfolio forward in a collaborative environment. He is the primary inventor and author on five provisional patents on candidate drugs and their response associations with predictive gene signatures and rare disease indications. Dr. Kulkarni is a collaborator experienced in working with academic and industrial research partners such as the National Cancer Institute (NCI), Fox Chase Cancer Center, Johns Hopkins University, Charles River Laboratories and Champions Oncology to drive results in a time-efficient and innovative manner. A researcher familiar with the laboratory and the board room, Dr. Kulkarni is the co-author of 10 papers in academic journals, is skilled at needs identification, hypothesis generation, study design, protocol implementation and opportunity assessment related to oncology agents, indications, patients, and markets, and has knowledge of budgeting, timelines, business contracts, and intellectual property frameworks. He is adept at working with cross-functional teams including management, research, clinical development, machine learning and medical affairs experts to identify key gaps in scientific and clinical knowledge and to synthesize research plans to generate or leverage the appropriate data, either internally or via research collaborations. Dr. Kulkarni holds a Ph.D. in Biochemistry and Molecular Biology from Baylor College of Medicine in Houston, Texas and a Bachelor of Technology in Pharmaceutics from the Institute of Chemical Technology in Mumbai, India.